Pharmafile Logo
Pharmafocus logo
Advanced Search

UroGen and MD Anderson to collaborate on bladder cancer treatment

January 14, 2021
Cancer, UroGen Pharma

UroGen Pharma, a biopharmaceutical company dedicated to treating specialty cancers and urologic diseases, and The University of Texas MD Anderson …

News
image_readtop_2018_569751_15365546683454581

Celltrion announces positive top-line results from COVID-19 treatment trial

January 14, 2021
COVID-19, celltrion

Celltrion Group has announced that top-line results from its global Phase II/III clinical trial of CT-P59, an anti-COVID-19 monoclonal antibody …

News

Novartis’ ligelizumab granted FDA Breakthrough Therapy Designation

January 14, 2021
FDA, Novartis

The FDA has granted Novartis’ ligelizumab Breakthrough Therapy Designation for the treatment of chronic spontaneous urticaria (CSU) in patients who …

News
credit_-_daniel_leal-olivas-afp

COVID-19 vaccine data leaked online by hackers, EMA says

January 14, 2021
EMA, Pfizer, Vaccine, data

The EMA has confirmed that data relating to COVID-19 medicines and vaccines that was stolen by hackers in December have …

News
screenshot_2021-01-14_file_beigene_ltd_-_panoramio_1_jpg_-_wikimedia_commons

BeiGene’s tislelizumab gets China approval for non-small cell lung cancer

January 14, 2021
BeiGene, Cancer, tislelizumab

BeiGene Ltd has announced that its anti-PD-1 antibody tislelizumab has received approval from the China National Medical Products Administration (NMPA) …

News
landing-hero-images1

ViiV gets EU approval for children’s HIV treatment

January 13, 2021
Research and Development EU, HIV, ViiV

ViiV Healthcare, the global specialist HIV company, has received marketing authorisation from the European Commission for Tivicay (dolutegravir) 5mg dispersible …

News
turkey_flag

Diurnal joins Er-Kim to distribute cortisol deficiency treatments in Turkey

January 13, 2021
Research and Development Diurnal, Diurnal Group, Er-Kim, Turkey

Diurnal Group, a specialty pharmaceutical company targeting patient needs in chronic endocrine diseases, has announced a distribution agreement with Er-Kim, …

News

Pfizer invests $25m in Vedanta BioSciences’ IBD treatment

January 13, 2021
Research and Development Pfizer, Vedanta Biosciences, inflammatory bowel disease

Pfizer has invested $25 million in Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases, …

News

Trial of potential new COVID-19 treatment begins in UK

January 13, 2021
Research and Development COVID-19, Synairgen, Vaccine

A large-scale trial of a new COVID-19 treatment to prevent severe illness in coronavirus patients has begun in the UK. …

News
moderna_norwood_plant

Switzerland approves Moderna’s COVID-19 vaccine

January 13, 2021
Research and Development COVID-19, Moderna, Vaccine

Moderna has announced that its COVID-19 vaccine has been authorised for use on those aged 18 or older in Switzerland. …

News
novartis_outside_1

Novartis and BeiGene join forces to develop cancer drug tislelizumab

January 12, 2021
Manufacturing and Production BeiGene, Cancer, Novartis

Novartis has signed a strategic collaboration agreement to in-license tislelizumab from BeiGene Ltd in major markets outside of China, accelerating …

News
sos002

Sosei Heptares and PharmEnable collaborate on neurological drug research

January 12, 2021
Manufacturing and Production PharmEnable, Sosei Heptares

Sosei Group Corporation and PharmEnable, a UK drug discovery company, have joined forces to apply their respective technologies to drive …

News
astrazeneca-sign

AstraZeneca seeks EU approval for COVID-19 vaccine

January 12, 2021
Manufacturing and Production AstraZeneca, COVID-19, Vaccine

AstraZeneca has applied for conditional marketing authorisation (CMA) from the EMA for its COVID-19 vaccine. CMA is used as the …

News

Boehringer Ingelheim and Enara Bio to collaborate on cancer immunotherapies

January 12, 2021
Manufacturing and Production Boehringer Ingelheim, Cancer, Enara Bio

Boehringer Ingelheim and Enara Bio have entered into a strategic collaboration and licensing agreement to research and develop novel targeted …

News

Promising new treatment for drug-resistant prostate cancer

January 12, 2021
Manufacturing and Production Cancer

A new experimental drug could offer a promising treatment strategy for men with advanced, drug-resistant prostate cancer, researchers have said. …

News
richard_francis

Purespring Therapeutics to appoint Richard Francis as CEO

January 11, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Purespring Therapeutics, a kidney-focused AAV gene therapy company, has announced it will appoint Richard Francis as Chief Executive Officer from …

Appointment
lilly_building_with_american_flag_web

Eli Lilly’s Alzheimer’s drug slows clinical decline in Phase II trial

January 11, 2021
Sales and Marketing Alzheimer's, Eli Lilly

Eli Lilly’s donanemab has shown significant slowing of decline in a composite measure of cognition and daily function in patients …

News
roche_dark_0

Roche’s influenza drug Xofluza gets EU approval

January 11, 2021
Sales and Marketing EC, Roche, influenza

The European Commission (EC) has approved Roche’s Xofluza (baloxavir marboxil) for the treatment of uncomplicated influenza in patients aged 12 …

News

MaxCyte signs licensing deal with Myeloid Therapeutics

January 11, 2021
Sales and Marketing MaxCyte, Myeloid Therapeutics

MaxCyte, a global cell-based therapies and life sciences company, and Myeloid Therapeutics, a company harnessing and reprogramming myeloid cells to …

News

Sanofi to acquire Kymab for $1.1bn

January 11, 2021
Sales and Marketing Malin, Sanofi, kymab

Sanofi is to acquire clinical-stage biopharmaceutical company Kymab for approximately $1.1 billion. In addition to this upfront sum, Paris-headquartered Sanofi …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025